Weltweite Psychiatrisierung durch Peter Henningsen
Verfasst: Freitag 12. Juni 2009, 04:17http://meagenda.wordpress.com/category/who-collaborating-centre/
Näheres siehe auf der Website unter dem markierten Link: EACLPP Working group on MUS version 16 Jan 2009
Auszugsweise von der Website
News:
Working Groups
Medically Unexplained Symptoms and Somatisation
Patients with medically unexplained symptoms and somatisation – a challenge for European health care systems
A white paper of the EACLPP Medically Unexplained Symptoms study group
by Peter Henningsen and Francis Creed can be downloaded at:
http://www.eaclpp.org/documents/Patientswithmedicallyunexplainedsymptomsandsomatisation.doc
“You can see the first draft of the report following the above link.
It is still “work in progress” and will be revised further.
“If you have any comments or additions to suggest, please email them to Gill
Dunkerley ( Gillian.D.Dunkerley@manchester.ac.uk ) who will pass them on to the
working group.”
Draft document is approx 76 pages long, including tables and charts can also be opened here
EACLPP Working group on MUS version 16 Jan 2009
(Let me know if there are any problems opening this draft report.)
A white paper of the EACLPP Medically Unexplained Symptoms study group
Patients with medically unexplained symptoms and somatisation – a challenge for
European health care systems
Draft – prepared by: Peter Henningsen and Francis Creed January 2009
“The report arises from the EACLPP working group “Improving the management of patients with medically unexplained symptoms/somatisation”. The group is open to all EACLPP members but a core group have been responsible for the fist draft of this report . The core group (listed below) includes (24 – to be revised?) members, who have contributed so far. They represent 9 EU countries (currently – increase?). All have a special interest in the treatment of patients with medically unexplained symptoms; most have a research interest as well as clinical one and all are motivated to see an improvement in the treatment of these patients who are served poorly by most, if not all, health care systems across Europe.”
Näheres siehe auf der Website unter dem markierten Link: EACLPP Working group on MUS version 16 Jan 2009
Auszugsweise von der Website
News:
Working Groups
Medically Unexplained Symptoms and Somatisation
Patients with medically unexplained symptoms and somatisation – a challenge for European health care systems
A white paper of the EACLPP Medically Unexplained Symptoms study group
by Peter Henningsen and Francis Creed can be downloaded at:
http://www.eaclpp.org/documents/Patientswithmedicallyunexplainedsymptomsandsomatisation.doc
“You can see the first draft of the report following the above link.
It is still “work in progress” and will be revised further.
“If you have any comments or additions to suggest, please email them to Gill
Dunkerley ( Gillian.D.Dunkerley@manchester.ac.uk ) who will pass them on to the
working group.”
Draft document is approx 76 pages long, including tables and charts can also be opened here
EACLPP Working group on MUS version 16 Jan 2009
(Let me know if there are any problems opening this draft report.)
A white paper of the EACLPP Medically Unexplained Symptoms study group
Patients with medically unexplained symptoms and somatisation – a challenge for
European health care systems
Draft – prepared by: Peter Henningsen and Francis Creed January 2009
“The report arises from the EACLPP working group “Improving the management of patients with medically unexplained symptoms/somatisation”. The group is open to all EACLPP members but a core group have been responsible for the fist draft of this report . The core group (listed below) includes (24 – to be revised?) members, who have contributed so far. They represent 9 EU countries (currently – increase?). All have a special interest in the treatment of patients with medically unexplained symptoms; most have a research interest as well as clinical one and all are motivated to see an improvement in the treatment of these patients who are served poorly by most, if not all, health care systems across Europe.”